Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Feb 22, 2023 | Sale | $37.30 | 23,333 | 870,239 | 46,667 | Feb 24, 2023, 06:26 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Jul 25, 2022 | Sale | $43.05 | 3,600 | 154,985 | 19,734 | Jul 27, 2022, 06:17 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Jul 26, 2022 | Sale | $43.20 | 19,734 | 852,461 | 0 | Jul 27, 2022, 06:17 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Jun 24, 2022 | Sale | $43.19 | 23,333 | 1,007,694 | 23,334 | Jun 24, 2022, 05:19 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | May 16, 2022 | Sale | $39.85 | 23,333 | 929,836 | 46,667 | May 16, 2022, 07:14 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP & Co-Head of R&I | Jun 04, 2021 | Sale | $45.13 | 16,566 | 747,662 | 16,568 | Jun 08, 2021, 08:15 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP & Co-Head of R&I | Jun 07, 2021 | Sale | $47.02 | 16,568 | 779,059 | 0 | Jun 08, 2021, 08:15 PM |